Delivery Order SPE2DB20D3104-SPE2DB25FV5P4

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,631.94, is a delivery order for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.08 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.90, is for the delivery of Telmisartan-Amlodipine 80-5 mg tablets in 30-count packages. The contract has a firm fixed price and is set to expire on November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.58 fixed-price delivery order is for the supply of Telmisartan-Amlodipine 40-5 mg tablets, supporting medical care and healthcare programs for the U.S. military and other federal beneficiaries. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,826.84 and an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will supply these pharmaceutical products to support various government agencies and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,005.00. It has an ultimate completion date of July 31, 2024. This award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, will be providing these essential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.53 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $1,514.74, for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has an Ultimate Completion Date of November 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,681.20, is for the delivery of Telmisartan-Amlodipine 40-10 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.54 firm fixed-price delivery order is for the supply of 4,567,299,271 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV5P4
    Delivery Order

This federal contract award, valued at $2,648.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan-Amlodipine 40-5 mg tablets, which are used to treat cardiovascular conditions. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price agreement.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/30/25, 10:02 AM